查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1590910

头颈癌诊断市场：按诊断方法和最终用户划分 - 全球预测 2025-2030

Head & Neck Cancer Diagnostics Market by Diagnostic Method (Bioscopy Screening, Blood Tests, Dental Diagnostic), End User (Diagnostic Centers, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年头颈癌诊断市场价值为17.4亿美元，预计到2024年将达到20.3亿美元，复合年增长率为16.78%，到2030年将达到51.6亿美元，预计将达到1000万美元。

头颈癌诊断市场范围涵盖广泛的诊断技术和工具，用于识别口腔、咽、喉、鼻窦和唾液腺的癌症。这个市场至关重要，因为头颈癌盛行率不断上升，需要先进的早期诊断方法来提高治疗效果。诊断应用范围从 CT 和 MRI 扫描等影像检查到切片检查、血液测试以及准确识别癌症类型和阶段的新分子诊断。最终用途范围主要包括医院、诊断实验室和研究机构，以执行和创新这些诊断程序。

主要市场统计
基准年[2023] 17.4亿美元
预测年份 [2024] 20.3亿美元
预测年份 [2030] 51.6亿美元
复合年增长率（%） 16.78%

诊断工具的技术进步、医疗保健支出的增加以及头颈癌早期检测意识的提高对市场成长产生了重大影响。此外，医疗保健基础设施投资的快速成长，特别是在新兴国家，为市场扩张提供了机会。鼓励市场上的公司专注于个人化医疗和非侵入性诊断技术，例如液态切片和新型生物标誌物，这些技术可以在最小化患者不适的情况下使用，因为它可以提供准确和快速的结果，因此越来越受欢迎。与生物技术公司合作开发次世代定序技术也可能提供宝贵的机会。

儘管存在这些机会，但先进诊断设备的高成本、某些地区获得医疗保健的机会有限以及严格的监管通讯协定等挑战可能会抑製成长。此外，癌症发生和进展的变异性强调需要持续研究以提高诊断准确性和治疗结果。最佳创新领域包括人工智慧在诊断中的整合、携带式诊断设备的开发以及远端医疗能力的进步以扩大诊断覆盖范围。随着技术的快速整合和对以患者为中心的医疗保健解决方案的日益重视，这个市场充满活力，这使得相关人员必须投资于研究和合作以保持竞争力。

市场动态：快速发展的头颈癌诊断市场的关键市场洞察

供需的动态交互作用正在改变头颈癌诊断市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球头颈癌盛行率
    • 增加政府和私营部门的癌症诊断倡议
    • 头颈癌诊断的核准增加
  • 市场限制因素
    • 设备高成本，报销情况不利
  • 市场机会
    • 诊断方法的新进展与创新
    • 为肿瘤学进步提供大量研究经费
  • 市场挑战
    • 缺乏训练有素的专业人员

波特五力策略工具引领头颈癌诊断市场

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解外部对头颈癌诊断药物市场的影响

外部宏观环境因素在塑造头颈癌诊断市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解头颈癌诊断药物市场的竞争状况

对头颈癌诊断市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 头颈癌诊断市场定位矩阵供应商绩效评估

FPNV定位矩阵是评估头颈癌诊断市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘头颈癌诊断市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，头颈癌诊断市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球头颈癌盛行率
      • 政府和私营部门在癌症诊断上加强力
      • 提高头颈癌诊断药物核准率
    • 抑制因素
      • 高成本，报销场景不利
    • 机会
      • 诊断调查方法的新进展与创新
      • 肿瘤学进展的主要研究经费
    • 任务
      • 缺乏训练有素的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依诊断方法分類的头颈癌诊断药物市场

  • 生物镜筛检
  • 验血
  • 牙科诊断
  • 诊断影像
  • 内视镜检查

第七章头颈癌诊断市场：依最终用户分类

  • 诊断中心
  • 医院

第八章北美和南美头颈癌诊断药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区头颈癌诊断药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲头颈癌诊断药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • AdDent, Inc.
  • Bristol Myers Squibb Company
  • Canon Inc.
  • Carestream Health Inc. by Koninklijke Philips NV
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • General Electric Company
  • KARL STORZ SE & Co. KG
  • Merck KGaA
  • Olympus Corporation
  • Optim LLC
  • Shimadzu Corporation
  • Siemens AG
  • Xoran Technologies LLC
Product Code: MRR-437E9896A540

The Head & Neck Cancer Diagnostics Market was valued at USD 1.74 billion in 2023, expected to reach USD 2.03 billion in 2024, and is projected to grow at a CAGR of 16.78%, to USD 5.16 billion by 2030.

The scope of the Head & Neck Cancer Diagnostics market encompasses a wide array of diagnostic techniques and tools utilized in identifying cancers of the oral cavity, pharynx, larynx, paranasal sinuses, and salivary glands. This market is crucial due to the rising prevalence of head and neck cancers, necessitating advanced and early diagnostic methods to enhance treatment efficacy. Diagnostics applications range from imaging tests, such as CT and MRI scans, to biopsy procedures, blood tests, and emerging molecular diagnostics that offer precision in identifying cancer type and stage. The end-use scope primarily includes hospitals, diagnostic laboratories, and research institutions that perform and innovate these diagnostic procedures.

KEY MARKET STATISTICS
Base Year [2023] USD 1.74 billion
Estimated Year [2024] USD 2.03 billion
Forecast Year [2030] USD 5.16 billion
CAGR (%) 16.78%

Market growth is significantly influenced by technological advancements in diagnostic tools, increased healthcare expenditure, and heightened awareness about the early detection of head & neck cancers. Moreover, the surge in healthcare infrastructure investments, particularly in emerging economies, presents a lucrative opportunity for market expansion. Companies in the market are encouraged to focus on personalized medicine and non-invasive diagnostic techniques, such as liquid biopsies and novel biomarkers, which are gaining traction due to their ability to offer accurate and quick results with minimal discomfort to patients. Partnerships with biotechnology firms for the development of next-generation sequencing techniques can also provide valuable opportunities.

Despite these opportunities, challenges such as the high costs of advanced diagnostic equipment, limited healthcare access in certain regions, and stringent regulatory protocols can impede growth. Furthermore, variability in cancer presentation and progression underscores the necessity for continuous research to improve diagnostic accuracy and treatment outcomes. The best areas for innovation include the integration of artificial intelligence in diagnostics, development of portable diagnostic devices, and advancements in telemedicine capabilities to extend diagnostic reach. This market is dynamic, driven by rapid technological integration and a growing emphasis on patient-centric healthcare solutions, making it essential for stakeholders to invest in research and collaboration to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Head & Neck Cancer Diagnostics Market

The Head & Neck Cancer Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of head and neck cancer worldwide
    • Rise in government and private body initiatives for cancer diagnostics
    • Increased approval for head & neck cancer diagnostics
  • Market Restraints
    • High cost of the devices and unfavorable reimbursement scenarios
  • Market Opportunities
    • New advancements and innovations in diagnostic methodology
    • Large research funding in oncological advancement
  • Market Challenges
    • Dearth of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Head & Neck Cancer Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Head & Neck Cancer Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Head & Neck Cancer Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Head & Neck Cancer Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Head & Neck Cancer Diagnostics Market

A detailed market share analysis in the Head & Neck Cancer Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Head & Neck Cancer Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Head & Neck Cancer Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Head & Neck Cancer Diagnostics Market

A strategic analysis of the Head & Neck Cancer Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Head & Neck Cancer Diagnostics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AdDent, Inc., Bristol Myers Squibb Company, Canon Inc., Carestream Health Inc. by Koninklijke Philips N.V., Esaote S.p.A., FUJIFILM Holdings Corporation, General Electric Company, KARL STORZ SE & Co. KG, Merck KGaA, Olympus Corporation, Optim LLC, Shimadzu Corporation, Siemens AG, and Xoran Technologies LLC.

Market Segmentation & Coverage

This research report categorizes the Head & Neck Cancer Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Diagnostic Method, market is studied across Bioscopy Screening, Blood Tests, Dental Diagnostic, Diagnostic Imaging, and Endoscopy Screening.
  • Based on End User, market is studied across Diagnostic Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of head and neck cancer worldwide
      • 5.1.1.2. Rise in government and private body initiatives for cancer diagnostics
      • 5.1.1.3. Increased approval for head & neck cancer diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the devices and unfavorable reimbursement scenarios
    • 5.1.3. Opportunities
      • 5.1.3.1. New advancements and innovations in diagnostic methodology
      • 5.1.3.2. Large research funding in oncological advancement
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Head & Neck Cancer Diagnostics Market, by Diagnostic Method

  • 6.1. Introduction
  • 6.2. Bioscopy Screening
  • 6.3. Blood Tests
  • 6.4. Dental Diagnostic
  • 6.5. Diagnostic Imaging
  • 6.6. Endoscopy Screening

7. Head & Neck Cancer Diagnostics Market, by End User

  • 7.1. Introduction
  • 7.2. Diagnostic Centers
  • 7.3. Hospitals

8. Americas Head & Neck Cancer Diagnostics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Head & Neck Cancer Diagnostics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Head & Neck Cancer Diagnostics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AdDent, Inc.
  • 3. Bristol Myers Squibb Company
  • 4. Canon Inc.
  • 5. Carestream Health Inc. by Koninklijke Philips N.V.
  • 6. Esaote S.p.A.
  • 7. FUJIFILM Holdings Corporation
  • 8. General Electric Company
  • 9. KARL STORZ SE & Co. KG
  • 10. Merck KGaA
  • 11. Olympus Corporation
  • 12. Optim LLC
  • 13. Shimadzu Corporation
  • 14. Siemens AG
  • 15. Xoran Technologies LLC

LIST OF FIGURES

  • FIGURE 1. HEAD & NECK CANCER DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HEAD & NECK CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HEAD & NECK CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HEAD & NECK CANCER DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HEAD & NECK CANCER DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BIOSCOPY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DENTAL DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY ENDOSCOPY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM HEAD & NECK CANCER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. HEAD & NECK CANCER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. HEAD & NECK CANCER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023